Last edition
News about "Latanoprostene Bunod Ophthalmic Solution"
Gland Pharma Gets Tentative Approval from USFDA for Latanoprostene Bunod Ophthalmic Solution
Gland Pharma Ltd. has secured tentative approval from the United States Food and Drug Administration (USFDA) for Latanoprostene Bunod Ophthalmic Solution, 0.024 percent.
Latanoprostene Bunod Ophthalmic Solution | 24/07/2024 | By Aishwarya | 249
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members